These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 28252460)

  • 21. Survival and Gastrostomy Prevalence in Patients With Oropharyngeal Cancer Treated With Transoral Robotic Surgery vs Chemoradiotherapy.
    Sharma A; Patel S; Baik FM; Mathison G; Pierce BH; Khariwala SS; Yueh B; Schwartz SM; Méndez E
    JAMA Otolaryngol Head Neck Surg; 2016 Jul; 142(7):691-7. PubMed ID: 27347780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 30-day morbidity and mortality after transoral robotic surgery for human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma: A retrospective analysis of two prospective adjuvant de-escalation trials (MC1273 & MC1675).
    Haller TJ; Yin XL; O'Byrne TJ; Moore EJ; Ma DJ; Price KP; Patel SH; Hinni ML; Neben-Wittich MA; McGee LA; Price DL; Janus JR; Kasperbauer JK; Nagel TH; Routman DM; Lester SC; Rwigema JCM; Chintakuntlawar AV; Savvides PS; Garcia JJ; Foote RL; Van Abel KM
    Oral Oncol; 2023 Feb; 137():106248. PubMed ID: 36603364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transoral robotic surgery and intensity-modulated radiotherapy in the treatment of the oropharyngeal carcinoma: a systematic review and meta-analysis.
    De Virgilio A; Costantino A; Mercante G; Pellini R; Ferreli F; Malvezzi L; Colombo G; Cugini G; Petruzzi G; Spriano G
    Eur Arch Otorhinolaryngol; 2021 May; 278(5):1321-1335. PubMed ID: 32696250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A systematic review on Transoral robotic surgery (TORS) for carcinoma of unknown primary origin: Has tongue base mucosectomy become indispensable?
    van Weert S; Rijken JA; Plantone F; Bloemena E; Vergeer MR; Lissenberg-Witte BI; Leemans CR
    Clin Otolaryngol; 2020 Sep; 45(5):732-738. PubMed ID: 32369264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utility of up-front transoral robotic surgery in tailoring adjuvant therapy.
    Gildener-Leapman N; Kim J; Abberbock S; Choby GW; Mandal R; Duvvuri U; Ferris RL; Kim S
    Head Neck; 2016 Aug; 38(8):1201-7. PubMed ID: 27225507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncologic, functional and surgical outcomes of primary Transoral Robotic Surgery for early squamous cell cancer of the oropharynx: a systematic review.
    Kelly K; Johnson-Obaseki S; Lumingu J; Corsten M
    Oral Oncol; 2014 Aug; 50(8):696-703. PubMed ID: 24917389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trans-oral robotic surgery for the management of oropharyngeal carcinomas: a 9-year institutional experience.
    Meccariello G; Montevecchi F; D'Agostino G; Iannella G; Calpona S; Parisi E; Costantini M; Cammaroto G; Gobbi R; Firinu E; Sgarzani R; Nestola D; Bellini C; De Vito A; Amadori E; Vicini C
    Acta Otorhinolaryngol Ital; 2019 Apr; 39(2):75-83. PubMed ID: 31097824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in Diagnosis and Multidisciplinary Management of Oropharyngeal Squamous Cell Carcinoma: State of the Art.
    Parvathaneni U; Lavertu P; Gibson MK; Glastonbury CM
    Radiographics; 2019; 39(7):2055-2068. PubMed ID: 31603733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transoral robotic versus open surgical approaches to oropharyngeal squamous cell carcinoma by human papillomavirus status.
    Ford SE; Brandwein-Gensler M; Carroll WR; Rosenthal EL; Magnuson JS
    Otolaryngol Head Neck Surg; 2014 Oct; 151(4):606-11. PubMed ID: 25049265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment De-escalation in Oropharyngeal Carcinoma and the Role of Robotic Surgery.
    Ceremsak J; Ye W; Hicks M; Mannion K
    Surg Oncol Clin N Am; 2024 Oct; 33(4):697-709. PubMed ID: 39244288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgery Versus Radiotherapy for Early Oropharyngeal Tumors: a Never-Ending Debate.
    Monnier Y; Simon C
    Curr Treat Options Oncol; 2015 Sep; 16(9):42. PubMed ID: 26187797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oropharyngeal cancer treatment: the role of transoral surgery.
    Hinni ML; Nagel T; Howard B
    Curr Opin Otolaryngol Head Neck Surg; 2015 Apr; 23(2):132-8. PubMed ID: 25761152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utilization of Transoral Robotic Surgery (TORS) in patients with Oropharyngeal Squamous Cell Carcinoma and its impact on survival and use of chemotherapy.
    Baliga S; Kabarriti R; Jiang J; Mehta V; Guha C; Kalnicki S; Smith RV; Garg MK
    Oral Oncol; 2018 Nov; 86():75-80. PubMed ID: 30409323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role of Surgery in the Management of Recurrent Oropharyngeal Cancer.
    Gross ND; Hanna EY
    Recent Results Cancer Res; 2017; 206():197-205. PubMed ID: 27699540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A benchmark for oncologic outcomes and model for lethal recurrence risk after transoral robotic resection of HPV-related oropharyngeal cancers.
    Brody RM; Shimunov D; Cohen RB; Lin A; Lukens JN; Hartner L; Aggarwal C; Duvvuri U; Montone KT; Jalaly JB; LiVolsi VA; Carey RM; Shanti RM; Rajasekaran K; Chalian AA; Rassekh CH; Cannady SB; Newman JG; O'Malley BW; Weinstein GS; Gimotty PA; Basu D
    Oral Oncol; 2022 Apr; 127():105798. PubMed ID: 35245888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of transoral robotic surgery on the overall treatment of oropharyngeal cancer patients.
    Smith RV; Schiff BA; Garg M; Haigentz M
    Laryngoscope; 2015 Nov; 125 Suppl 10():S1-S15. PubMed ID: 26436491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical value of transoral robotic surgery: Nationwide results from the first 5 years of adoption.
    Li H; Torabi SJ; Park HS; Yarbrough WG; Mehra S; Choi R; Judson BL
    Laryngoscope; 2019 Aug; 129(8):1844-1855. PubMed ID: 30575965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial.
    Nichols AC; Theurer J; Prisman E; Read N; Berthelet E; Tran E; Fung K; de Almeida JR; Bayley A; Goldstein DP; Hier M; Sultanem K; Richardson K; Mlynarek A; Krishnan S; Le H; Yoo J; MacNeil SD; Winquist E; Hammond JA; Venkatesan V; Kuruvilla S; Warner A; Mitchell S; Chen J; Corsten M; Johnson-Obaseki S; Eapen L; Odell M; Parker C; Wehrli B; Kwan K; Palma DA
    Lancet Oncol; 2019 Oct; 20(10):1349-1359. PubMed ID: 31416685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Salvage surgery for recurrent cancers of the oropharynx: comparing TORS with standard open surgical approaches.
    White H; Ford S; Bush B; Holsinger FC; Moore E; Ghanem T; Carroll W; Rosenthal E; Sweeny L; Magnuson JS
    JAMA Otolaryngol Head Neck Surg; 2013 Aug; 139(8):773-8. PubMed ID: 23949352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is There a Role for Robotic Surgery in the Treatment of Head and Neck Cancer?
    Byrd JK; Ferris RL
    Curr Treat Options Oncol; 2016 Jun; 17(6):29. PubMed ID: 27117980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.